Citadel Advisors - PROMETHEUS BIOSCIENCES INC ownership

PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 103 filers reported holding PROMETHEUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PROMETHEUS BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$20,288,417
-67.9%
189,046
-67.1%
0.01%
-66.7%
Q4 2022$63,220,960
+624.9%
574,736
+288.9%
0.02%
+650.0%
Q3 2022$8,721,000
-56.9%
147,800
-79.4%
0.00%
-60.0%
Q2 2022$20,251,000
+2086.9%
717,403
+2828.5%
0.01%
Q1 2022$926,000
-1.9%
24,497
-36.3%
0.00%
Q2 2021$944,000
-7.9%
38,438
-31.5%
0.00%
Q1 2021$1,025,00056,1380.00%
Other shareholders
PROMETHEUS BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 1,848,024$198,329,93693.93%
CHI Advisors LLC 934,135$100,251,36726.61%
Cormorant Asset Management, LP 1,655,000$177,61511.70%
Boxer Capital, LLC 1,897,500$203,64010.00%
RTW INVESTMENTS, LP 3,272,104$351,162,2017.31%
Decheng Capital Management III (Cayman), LLC 150,000$16,098,0006.50%
Waypoint Capital Advisors, LLC 154,466$16,577,2925.40%
Affinity Asset Advisors, LLC 150,000$16,098,0005.31%
Perceptive Advisors 1,272,694$136,585,5204.03%
Ikarian Capital, LLC 125,926$13,514,3783.07%
View complete list of PROMETHEUS BIOSCIENCES INC shareholders